Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BCORNYSEARCA:BNENYSEARCA:KPRONYSEARCA:THNR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBCORBlucora$29.64-6.0%$25.54$15.10▼$27.75$1.43B1.25313,650 shs3,860 shsBNEBlue Horizon BNE ETF$22.49+1.2%$22.49$19.53▼$23.78$4.50M1.32931 shs1,700 shsKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETF$28.13+0.1%$27.95$25.76▼$28.41$2.81M0.32743 shs3 shsTHNRAmplify Weight Loss Drug & Treatment ETF$21.62+0.6%$21.10$18.56▼$28.19$2.81MN/A3,124 shs1,430 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBCORBlucora-6.30%+10.98%+15.99%+15.99%+15.99%BNEBlue Horizon BNE ETF0.00%0.00%0.00%0.00%-4.09%KPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETF+0.07%+0.07%+1.04%+0.50%+7.24%THNRAmplify Weight Loss Drug & Treatment ETF+0.56%-0.69%+4.65%-6.93%-14.51%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBCORBlucoraN/AN/AN/AN/AN/AN/AN/AN/ABNEBlue Horizon BNE ETFN/AN/AN/AN/AN/AN/AN/AN/AKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETFN/AN/AN/AN/AN/AN/AN/AN/ATHNRAmplify Weight Loss Drug & Treatment ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBCORBlucora 0.00N/AN/AN/ABNEBlue Horizon BNE ETF 2.56Moderate Buy$22.49N/AKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETF 0.00N/AN/AN/ATHNRAmplify Weight Loss Drug & Treatment ETF 2.66Moderate Buy$21.62N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBCORBlucora$885.20M1.61$2.62 per share11.33$7.01 per share4.23BNEBlue Horizon BNE ETFN/AN/AN/AN/AN/AN/AKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETFN/AN/AN/AN/AN/AN/ATHNRAmplify Weight Loss Drug & Treatment ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBCORBlucora$7.76M$0.5652.9313.170.813.12%15.60%5.29%N/ABNEBlue Horizon BNE ETFN/AN/A13.74∞N/AN/AN/AN/AN/AKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETFN/AN/A17.79∞N/AN/AN/AN/AN/ATHNRAmplify Weight Loss Drug & Treatment ETFN/AN/A25.21∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBCORBlucoraN/AN/AN/AN/AN/ABNEBlue Horizon BNE ETF$0.060.27%N/AN/AN/AKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETF$1.003.55%N/AN/AN/ATHNRAmplify Weight Loss Drug & Treatment ETF$0.221.02%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBCORBlucora1.402.512.51BNEBlue Horizon BNE ETFN/AN/AN/AKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETFN/AN/AN/ATHNRAmplify Weight Loss Drug & Treatment ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBCORBlucora92.35%BNEBlue Horizon BNE ETFN/AKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETFN/ATHNRAmplify Weight Loss Drug & Treatment ETFN/AInsider OwnershipCompanyInsider OwnershipBCORBlucora2.35%BNEBlue Horizon BNE ETFN/AKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETFN/ATHNRAmplify Weight Loss Drug & Treatment ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBCORBlucora1,10048.14 million47.01 millionNo DataBNEBlue Horizon BNE ETFN/A200,000N/ANot OptionableKPROKraneShares 100% KWEB Defined Outcome Through January 2026 ETFN/A100,002N/AN/ATHNRAmplify Weight Loss Drug & Treatment ETFN/A130,000N/AN/AKPRO, BNE, THNR, and BCOR HeadlinesRecent News About These CompaniesNew Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFsJanuary 17, 2025 | etftrends.comDisruptive Theme of the Week – Breakthroughs in MedicineNovember 21, 2024 | etftrends.comAmplify ETFs Hits $10 Billion in Assets Amid New ETF LaunchesOctober 29, 2024 | etftrends.comTap the Weight-Loss Drug Market With These ETFsSeptember 18, 2024 | zacks.comDisruptive Theme of the Week: Playing DefenseAugust 14, 2024 | etftrends.comETFs in Focus as Competition Heats Up in Weight Loss Drug SegmentJuly 22, 2024 | zacks.comTop Themes in the First Half of 2024: Crypto, Chips, Ships & SilverJuly 2, 2024 | etftrends.comWhy Investors Haven't Feasted on Two New Weight-Loss ETFsJune 24, 2024 | investopedia.comFinding Opportunity in Unloved Healthcare ETFsMay 31, 2024 | etftrends.comPlay These New ETFs to Tap Lucrative Weight Loss Drug MarketMay 22, 2024 | zacks.comKPRO, BNE, THNR, and BCOR Company DescriptionsBlucora NASDAQ:BCORAvantax, Inc. engages in the provision of integrated tax-focused wealth management services and software. It operates through the Wealth Management and Tax Preparation segments. The Wealth Management segment consists of the operations of Avantax, which provides tax-focused wealth management solutions for financial advisors, tax preparers, certified public accounting firms, and its clients. The Tax Preparation segment focuses on digital tax preparation solutions for consumers, small business owners, and tax professionals. The company was founded by Naveen Mahendra Kumar Jain in March 1996 and is headquartered in Dallas, TX.Blue Horizon BNE ETF NYSEARCA:BNE$22.49 +0.27 (+1.22%) As of 09/26/2024The Blue Horizon BNE ETF (BNE) is an exchange-traded fund that is based on the Blue Horizon New Energy Economy 100 index. The fund tracks an equal-weighted index of global stocks that are perceived to benefit from a New Energy Economy. BNE was launched on Dec 8, 2020 and is managed by Blue Horizon.KraneShares 100% KWEB Defined Outcome Through January 2026 ETF NYSEARCA:KPRO$28.13 +0.02 (+0.07%) As of 05/23/2025 04:10 PM EasternThe KraneShares 100% KWEB Defined Outcome January 2026 ETF (KPRO) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund seeks to track the total return of the KraneShares CSI China Internet ETF (KWEB) up to a cap, with a 100% downside hedge over a two-year outcome period. The actively managed fund holds shares of the underlying ETF and options to obtain exposure KPRO was launched on Feb 8, 2024 and is issued by KraneShares.Amplify Weight Loss Drug & Treatment ETF NYSEARCA:THNR$21.62 +0.12 (+0.56%) As of 05/23/2025 04:10 PM EasternThe Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund that is based on the VettaFi Weight Loss Drug index. The fund tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. THNR was launched on May 21, 2024 and is issued by Amplify Investments. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
